Literature DB >> 10830620

Differentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid.

A Voigt1, P Hartmann, F Zintl.   

Abstract

Because of the known property of spontaneous regression in stage IVS of neuroblastoma all attempts are made to elucidate whether differentiation inducers possibly could be applied for neuroblastoma therapy. Here we examined the influence of retinoic acid (RA) in vitro on differentiation, proliferation and adhesion of 10 permanent and 4 primary cell lines as well as of several SCID-mouse tumour transplants. In general, after RA treatment morphologically different cell types which are characteristic for neuroblastoma cells have changed. N (neuronal)-type cells prolonged their neuronal processes, whereas S (epithelial, substrate-adherent, Schwann cell-like)-type cells lost their adherence to substratum and became apoptotic. Additionally, the reactions of all neuroblastoma cell lines with monoclonal antibodies against beta-tubulin (for neuronal cells) and glial fibrillary acidic protein (for epithelial cells) were determined. The anti-proliferative effect of all-trans-RA as well as 13-cis-RA was more profound in S-type cells (up to 40% in primary cell lines). To elucidate the role of adhesion molecules during neuronal cell differentiation, we have analysed the adhesion of neuroblastoma cells on poly-D-lysin-precoated plates under RA influence. While N-type cells displayed an increased adhesion, all S-type cell lines as well as all primary cell lines exhibited a reduced adhesion (IMR-5 and IMR-32: p < 0.001; JW, SR and PM: p < 0.05). RA treatment increased predominantly the tested antigens (HCAM, ICAM-1, NCAM, PECAM-1, VCAM-1, cadherin, FGF-R, IGF-R, NGF-R, TGF-beta/1, NF200, NF160, NF68, NSE, HLA-ABC) in all cell lines independently of their phenotypes (TGF-beta/1: p < 0.001; NF68: p < 0.01; PECAM-1 and NGF-R: p < 0.05). In recultured SCID-mouse-passaged tumour cells antigens were down-regulated (FGF-R: p < 0.01), but increased again after RA influence (TGF-beta/1: p < 0.05). In summary, the RA differentiation model demonstrates the possibility to interfere in cell adhesion and to diminish growth potential both in N-type as well as S-type neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830620     DOI: 10.3109/15419060009109023

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  11 in total

1.  Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.

Authors:  Emily Harasym; Nicole McAndrew; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-08-24       Impact factor: 2.416

2.  An overview of neuroblastoma cell lineage phenotypes and in vitro models.

Authors:  Sheron Campos Cogo; Thatyanne Gradowski Farias da Costa do Nascimento; Fernanda de Almeida Brehm Pinhatti; Nilton de França Junior; Bruna Santos Rodrigues; Luciane Regina Cavalli; Selene Elifio-Esposito
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-12

3.  Nanoformulated Mutant SurR9-C84A: a Possible Key for Alzheimer's and its Associated Inflammation.

Authors:  Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Pharm Res       Date:  2015-03-14       Impact factor: 4.200

4.  Transient exposure of human bronchial epithelial cells to cytokines leads to persistent increased expression of ICAM-1.

Authors:  M C Subauste; D C Choi; D Proud
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

5.  Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.

Authors:  Erik H Knelson; Angela L Gaviglio; Jasmine C Nee; Mark D Starr; Andrew B Nixon; Stephen G Marcus; Gerard C Blobe
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

6.  Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells.

Authors:  Jana Hřebačková; Jitka Poljaková; Tomáš Eckschlager; Jan Hraběta; Pavel Procházka; Svatopluk Smutný; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2009-09-28

7.  DNA and histone deacetylases as targets for neuroblastoma treatment.

Authors:  Marie Stiborová; Jitka Poljaková; Tomáš Eckschlager; Rene Kizek; Eva Frei
Journal:  Interdiscip Toxicol       Date:  2010-06

8.  Maternal smoking and the retinoid pathway in the developing lung.

Authors:  Sara E Manoli; Lacey A Smith; Carrie A Vyhlidal; Chang Hyeok An; Yolanda Porrata; Wellington V Cardoso; Rebecca M Baron; Kathleen J Haley
Journal:  Respir Res       Date:  2012-06-01

9.  Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.

Authors:  Roman A Blaheta; Frederick H Daher; Martin Michaelis; Christoph Hasenberg; Eva M Weich; Dietger Jonas; Rouslan Kotchetkov; Hans Willhelm Doerr; Jindrich Cinatl
Journal:  BMC Cancer       Date:  2006-12-21       Impact factor: 4.430

10.  Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma.

Authors:  Marianna Szemes; Alexander Greenhough; Zsombor Melegh; Sally Malik; Aysen Yuksel; Daniel Catchpoole; Kelli Gallacher; Madhu Kollareddy; Ji Hyun Park; Karim Malik
Journal:  Neoplasia       Date:  2018-03-03       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.